Pharmaids Pharmaceuticals Limited (BOM:524572)
India · Delayed Price · Currency is INR 28.57
-0.52 (-1.79%)
At close: Nov 6, 2026
Pharmaids Pharmaceuticals Market Cap
Pharmaids Pharmaceuticals has a market cap or net worth of 1.01 billion as of November 6, 2026. It is the 40,901st most valuable company in the world and the 3,333rd biggest in India. Its market cap has decreased by 40.74% in one year.
Market Cap
1.01B
Enterprise Value
1.24B
Revenue
253.40M
Global Rank
Country Rank
#3,333 India
PE Ratio
n/a
ChartMarket Cap Chart
Since January 11, 2002, Pharmaids Pharmaceuticals's market cap has increased from 12.26M to 1.01B, an increase of 8,118.74%. That is a compound annual growth rate of 19.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.01B | -40.05% |
| Dec 31, 2025 | 1.68B | -32.38% |
| Dec 31, 2024 | 2.49B | 137.65% |
| Dec 29, 2023 | 1.05B | 185.46% |
| Dec 26, 2022 | 366.41M | 131.65% |
| Dec 31, 2021 | 158.17M | -6.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Makers Laboratories | 1.30B |
| Lactose (India) | 1.29B |
| Godavari Drugs | 1.21B |
| Parnax Lab | 1.17B |
| Concord Drugs | 937.53M |
| Parmax Pharma | 919.71M |
| Cian Healthcare | 905.75M |
| Mercury Laboratories | 900.00M |